Here, we present evidence that TMIGD1 binds to ERM family proteins (moesin and ezrin), regulates the stability of microtubules and modulates cell migration in renal cancer cells, implicating TMIGD1 as a potential cancer therapeutic target. The gene discussed is MSN; the disease is renal carcinoma.